Literature DB >> 19134052

The influence of retrograde reperfusion on the ischaemia-/reperfusion injury after liver transplantation in the rat.

Hans Kern1, Christian Bald, Thomas Brill, Falko Fend, Claus Hann von Weihern, Monika Kriner, Norbert Hüser, Stefan Thorban, Manfred Stangl, Edouard Matevossian.   

Abstract

Dysfunction of the graft after liver transplantation caused by ischaemia-/reperfusion (I/R) injury is a serious clinical problem. The aim of this study was to evaluate the influence of different kinds of reperfusion on I/R injury in a rat model. Arterialized orthoptic rat liver treatment was performed on male LEWIS-(RT(1))-rats. Three groups (n = 7) were formed. Group I: antegrade reperfusion with a 6-min delayed reperfusion via the hepatic artery. Group II: Antegrade reperfusion, simultaneously, via the portal vein and the hepatic artery. Group III: Retrograde reperfusion via the vena cava. Serum parameters were determined one, 24 and 48 h after operation. Furthermore, after 48 h, the liver was taken for histological assessment. After 48 h, rats of group III showed significantly lower aspartate amino transferase and alanine amino transferase serum levels compared with group I and group II rats. Forty-eight hours after transplantation, glutamate dehydrogenase serum level was significantly lower in group III than in group II. In histology, group III livers showed significantly less necrotic spots than group I and group II livers. Maximum size of the necrotic spots was significantly lower in group III than in group I. Also, significantly more necrotic spots were seen in the 'Rappaport's zone' 1 and 2 of group I than in group III. Our data suggested that the expression of I/R-injury correlates with the type of reperfusion. Furthermore, under standard conditions, this study was able to demonstrate that in a rat model, the retrograde reperfusion leads to a lower expression of I/R-injury than the antegrade reperfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19134052      PMCID: PMC2669604          DOI: 10.1111/j.1365-2613.2008.00616.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  18 in total

Review 1.  The sequence of revascularization in liver transplantation: it does make a difference.

Authors:  Wojciech G Polak; Robert J Porte
Journal:  Liver Transpl       Date:  2006-11       Impact factor: 5.799

2.  Simultaneous arterial and portal revascularization in liver transplantation.

Authors:  P C Massarollo; S Mies; S Raia
Journal:  Transplant Proc       Date:  1998-09       Impact factor: 1.066

3.  Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trial.

Authors:  Christoph Heidenhain; Michael Heise; Sven Jonas; Manuela Ben-Asseur; Gero Puhl; Jens Mittler; Armin Thelen; Sven Schmidt; Jan Langrehr; Peter Neuhaus
Journal:  Transpl Int       Date:  2006-09       Impact factor: 3.782

4.  Sequence of reperfusion influences ischemia/reperfusion injury and primary graft function following porcine liver transplantation.

Authors:  Jens G Brockmann; Christian August; Heiner H Wolters; Ralf Hömme; Daniel Palmes; Hideo Baba; Hans-U Spiegel; Karl H Dietl
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

5.  Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection.

Authors:  D C Snover; D K Freese; H L Sharp; J R Bloomer; J S Najarian; N L Ascher
Journal:  Am J Surg Pathol       Date:  1987-01       Impact factor: 6.394

6.  Primary dysfunction after liver transplantation. Is it possible to predict this complication?

Authors:  C Moreno Sanz; C Jiménez Romero; E Moreno González; I García García; I Seoane González; C Loinaz Segurola; M A García Ureña; A González Chamorro
Journal:  Rev Esp Enferm Dig       Date:  1999-06       Impact factor: 2.086

7.  The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury.

Authors:  Paolo Caraceni; Marco Domenicali; Gianluigi Vendemiale; Ignazio Grattagliano; Annamaria Pertosa; Bruno Nardo; Antonio Maria Morselli-Labate; Franco Trevisani; Giuseppe Palasciano; Emanuele Altomare; Mauro Bernardi
Journal:  J Surg Res       Date:  2005-04       Impact factor: 2.192

8.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  A single-center experience with retrograde reperfusion in liver transplantation.

Authors:  Daniela Kniepeiss; Florian Iberer; Barbara Grasser; Silvia Schaffellner; Vanessa Stadlbauer; Karl-Heinz Tscheliessnigg
Journal:  Transpl Int       Date:  2003-06-18       Impact factor: 3.782

10.  Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group.

Authors:  R J Porte; R J Ploeg; B Hansen; J H van Bockel; J Thorogood; G G Persijn; J Hermans; O T Terpstra
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

View more
  3 in total

1.  Hepatic arterial reconstruction for orthotopic liver transplantation in the rat.

Authors:  Tomohide Hori; Lindsay B Gardner; Feng Chen; Ann-Marie T Baine; Toshiyuki Hata; Aimee R Herdt; Shinji Uemoto; Christopher B Eckman; Justin H Nguyen
Journal:  J Surg Res       Date:  2012-05-09       Impact factor: 2.192

2.  Impact of hepatic arterial reconstruction on orthotopic liver transplantation in the rat.

Authors:  Tomohide Hori; Lindsay B Gardner; Florence Chen; Ann-Marie T Baine; Toshiyuki Hata; Shinji Uemoto; Justin H Nguyen
Journal:  J Invest Surg       Date:  2012-05-09       Impact factor: 2.533

3.  Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats.

Authors:  Shinichi Nakanuma; Hidehiro Tajima; Hiroyuki Takamura; Seisho Sakai; Ryosuke Gabata; Mitsuyoshi Okazaki; Hiroyuki Shinbashi; Yoshinao Ohbatake; Isamu Makino; Hironori Hayashi; Tomoharu Miyashita; Sachio Fushida; Tetsuo Ohta
Journal:  Ann Transplant       Date:  2020-07-14       Impact factor: 1.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.